Baixar PDF
1 / Páginas

Outros usuários também visualizaram estes artigos

Optimizing prognosis in atrial fibrillation: A call to action in Portugal Jorge Ferreira; Natália António; Nuno Cortez-Dias; Luciana Ricca Gonçalves; João Sargento-Freitas; Pedro von Hafe; Victor Gil;
Rev Port Cardiol. 2021;40:595-605
Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial Saghar Barati; Hossein Amini; Zargham Hossein Ahmadi; Alireza Dastan; Babak Sharif Kashani; Raha Eskandari; Farzaneh Dastan;
Rev Port Cardiol. 2023;42:139-44
Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke Luís Paiva; José Coelho; Sérgio Barra; Marco Costa; João Sargento-Freitas; Luís Cunha; Lino Gonçalves;
Rev Port Cardiol. 2021;40:357-65